Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action.
Natural history of multiple sclerosis symptoms.
Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
Optic neuritis revealing Kikuchi-Fujimoto disease.
[Case of neuromyelitis optica].
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis.
Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.
Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2.
Economic impact of multiple sclerosis in Italy: focus on rehabilitation costs.
Visual outcome following optic neuritis: A 5-year review.
[Does interferon beta slow the progression of multiple sclerosis? - Long-term effect of IFN-β on progression of physical disability is still not proven].
CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination.
Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Aggressive Multiple Sclerosis - whom, when and how.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.
Cerebrospinal Venous Outflow in Multiple Sclerosis Patients versus Fatigue and/or Depression.
Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis.
Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
MSX3 Switches Microglia Polarization and Protects from Inflammation-Induced Demyelination.
IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.
Gene expression analysis of histamine receptors in peripheral blood mononuclear cells from individuals with clinically-isolated syndrome and different stages of multiple sclerosis.
Current understanding of klotho.
Use of Functional Ambulation Performance Score as measurement of gait ability: Review.
Cannabidiol: promise and pitfalls.
Melatonin Redox Activity. Its Potential Clinical Application in Neurodegenerative Disorders.
Pages
« first
‹ previous
…
408
409
410
411
412
413
414
415
416
…
next ›
last »